Fan Zhou

Jing'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Clinicopathologic spectrum and outcomes of primary ovarian lymphoma: a retrospective case series.

Clinicopathologic spectrum and outcomes of primary ovarian lymphoma: a retrospective case series.

Journal: Leukemia & lymphoma

Published: June 07, 2026

Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol-Inspired Approach.

Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol-Inspired Approach.

Journal: Basic & clinical pharmacology & toxicology

Published: January 20, 2026

Detection and clinical significance of peripheral blood myeloid-derived suppressor cells in patients with multiple myeloma.

Detection and clinical significance of peripheral blood myeloid-derived suppressor cells in patients with multiple myeloma.

Journal: Medicine

Published: July 22, 2025

Development and validation of a prognostic staging system for primary plasma cell leukemia.

Development and validation of a prognostic staging system for primary plasma cell leukemia.

Journal: Journal of hematology & oncology

Published: April 30, 2025

Piwi-interacting RNA-823 promotes cell growth and chemoresistance by stimulating the TGF-β1-mediated AKT/ERK pathway in multiple myeloma.

Piwi-interacting RNA-823 promotes cell growth and chemoresistance by stimulating the TGF-β1-mediated AKT/ERK pathway in multiple myeloma.

Journal: International immunopharmacology

Published: March 31, 2025

Thrombotic events in patients with multiple myeloma and their impact on overall survival.

Thrombotic events in patients with multiple myeloma and their impact on overall survival.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 19, 2025

Clinicopathologic predictors of renal response and survival in newly diagnosed multiple myeloma with renal injury: a retrospective study.

Clinicopathologic predictors of renal response and survival in newly diagnosed multiple myeloma with renal injury: a retrospective study.

Journal: Clinical and experimental medicine

Published: November 07, 2024

Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma.

Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma.

Journal: American journal of cancer research

Published: September 12, 2024

PNPO-Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β-Catenin Pathway.

PNPO-Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β-Catenin Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 08, 2024

Cardiac infiltration of diffuse large B-cell lymphoma manifesting as sustained ventricular tachycardia: a case report.

Cardiac infiltration of diffuse large B-cell lymphoma manifesting as sustained ventricular tachycardia: a case report.

Journal: Journal of geriatric cardiology : JGC

Published: March 28, 2024

Comparative efficacy of novel-drugs combined therapeutic regimens on relapsed/refractory multiple myeloma: a network meta-analysis.

Comparative efficacy of novel-drugs combined therapeutic regimens on relapsed/refractory multiple myeloma: a network meta-analysis.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 21, 2023

Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.

Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications.

Journal: Frontiers in oncology

Published: March 14, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026